Eighth Edition - R.3 - Human Fertilisation & Embryology Authority

Index
of justification for use of
gametes/embryos, by clinician
T49(15)
quality management system T33(23), 23.5
review/revision and reapproval 31.6
reviews, history recorded
T34(31)
third party procurement of gametes/embryos 24.5
see also records
donor assisted conception T54(20), 20.1–20.14
access to information 20B, 20.10–20.14
conditions for
T54(20)
counselling for people treated 20.4, 20.9
implications of 20.9
importance of informing child
about donor origins T63(6), 20A, 20.7–20.8
information for donors 20B, 20.10
information for people
seeking treatment 20.1–20.6, 20.11, 20.12
number of treatment cycles 20.5
single donor to be used in a cycle 20.6
donor-conceived people
access to information 20.2d, 20.11, 20.12, 20.13
age for right to access to information 20.2d
importance of informing
about donor origins T63(6), 20A, 20.7–20.8
information available to about donors
see donors (embryos/gametes), information about
information provided to donors about 11B, 11.26–11.28,
20B, 20.10, 30B, 30.13
information types disclosed to 20.2c, 20.2d
see also child/children
donors (embryos/gametes) 11.1–11.41
10 family limit 11.7d, 11.24g, 11.33, 11.35–11.40
consent 11.33
documented procedures to control 11.35
monitoring and complying with 11.35–11.40
reaching, storage implications 17.16b
relevant treatment already started 11.38, 11.39–11.40
advertising/publicity for recruiting 11.1, 13.6
age of donors T52a(11), 11.2–11.5
restrictions for under 18 years of age 11.4
anonymous, right to re-register as identifiable 11.28
benefits in kind for sperm donors 11.41, 12.5
compensation see compensation for loss of earnings
conditions for use of gametes/embryos
from donors
T54(20)
consent T58(4), 5A, 5.18, 11D, 11.33–11.34
family number limit 11.33
information required before
T58(4)
partner’s support 5.19, 11.34
procedure for obtaining 5.7
refusal, implications 11.10
requirements for
5A
for research/training use of embryos/
gametes see research; training
storage of gametes 5A, 5.5, 12.7, 17B, 17.14
time to consider implications 5.7, 11.32
varying/withdrawing 5H, 11.24n
contact information of donors 11.24k
contact with, regarding expiry of storage time 17.18
counselling see counselling
death
consent for embryo use for research 22.7l, 22.20
consent to treatment and see consent
legal parenthood and see legal parenthood
disclosure of information about 20.1, 30.14–30.16
contacting/forewarning before 11.31, 30.13
genetic and other screening 20.3
genetic inheritance and
physical characteristics 20.1b
identifying 11.24j, 20.12, 30.13
non-identifying 11.24i, 11.24j, 20.1,
20.11, 30.14, 30.16
under statute 30A, 30.12
disclosure of information to,
about children born 11B, 11.26–11.28, 20B,
20.10, 30B, 30.13
egg see egg donors/providers
embryo donation
embryos from sperm produced at home 15.8
men donating embryos 5.20, 11.25
expenses, reimbursement
see expenses of donors
failure to provide information 11.8, 11.9b
family and medical history 11.8–11.10
refusal to give consent for 11.10
gamete donors/donation
conditions for use of gametes from
T54(20)
donor abnormalities T55(11), 11A,
11.12, 11.13a
donor identity, establishing by PGD
10B
information form, prior to
importing/exporting gametes
16A
overseas/import into UK 13.5
previous donation/use 11.7
procedure, informing donors on 11.24e
quarantine T53c(11), 11.16
selection of egg providers 12.1–12.3
specification of conditions for storage, consent 5.5
in surrogacy arrangement
14A
general enquiries about T52a(11), 11.6–11.7
genetic disease/carrier status
notification 11.21–11.23
prohibitions/restrictions on
use of donors with
T55(11)
identifiable donors
re-registering as 11.28, 11.30
registration date 11.30
identification, in witnessing 18.17–18.24
identifiers (identifying codes) for 18.5, 19.2a
identifying information on 11.30, 11.31, 30.13
disclosure 11.24j, 20.12, 30.13
identity confirmation see witnessing
Human Fertilisation and Embryology Authority
Index
Version 3.0